ArticleNPJ breast cancer2023

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

Zhi Ling Teo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.